Indications
For the temporary relief of dizziness, fatigue, nausea, weakened memory, or slow perception.*
Warnings and precautions
Consult a doctor if condition worsens or if symptoms persist. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy and breastfeeding
If pregnant or breastfeeding, ask a healthcare professional before use.
Packs
| Pack | Code | Status |
|---|---|---|
| LABEL-Hypotonia Drops 2030 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Source: U.S. Food and Drug Administration, Drugs@FDA and openFDA drug labels (imported 10 June 2026). Not endorsed by the FDA.
Licence: Public domain (U.S. Government work); openFDA terms · Added 10 Jun 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Hypotonia drops
- Register
- United States (FDA)
- Status
- Status unknown
- Procedure
- Label only